发明名称 |
Aptazyme capable of selective silencing of target miRNA by releasing an antisense sequence in hepatitis C virus-infected cells and use thereof |
摘要 |
The present invention relates to an aptazyme comprising an aptamer for hepatitis C virus (HCV) RNA-encoding component; a hammerhead ribozyme comprising an antisense sequence to microRNA at the site released by self-cleavage; and a communication module sequence that connects the aptamer and hammerhead ribozyme and triggers a self-cleavage activity of the hammerhead ribozyme upon binding of the aptamer with the HCV RNA-encoding component. The present aptazyme inhibits microRNA activity specifically in HCV proliferating cells and thus a composition of the present invention comprising the aptazyme can be effectively used for treatment of HCV-related diseases. |
申请公布号 |
US9284555(B2) |
申请公布日期 |
2016.03.15 |
申请号 |
US201113823845 |
申请日期 |
2011.09.16 |
申请人 |
Industry-Academic Cooperation Foundation Dankook University |
发明人 |
Lee Seong-Wook;Lee Chang-Ho |
分类号 |
C12N15/11;C12Q1/68;C12N15/113;C12N15/10 |
主分类号 |
C12N15/11 |
代理机构 |
McDonnell Boehnen Hulbert & Berghoff LLP |
代理人 |
McDonnell Boehnen Hulbert & Berghoff LLP |
主权项 |
1. An aptazyme capable of releasing an antisense sequence to microRNA specifically in HCV-infected cells, comprising:
an aptamer for hepatitis C virus (HCV) RNA-encoding component; a hammerhead ribozyme comprising an antisense sequence to microRNA at the site released by self-cleavage; and a communication module sequence that connects the aptamer and hammerhead ribozyme and includes self-cleavage activity of hammerhead ribozyme upon binding of the aptamer with the HCV RNA-encoding component, wherein nucleic acid sequence of the aptazyme is represented by SEQ ID NO: 12 or 13. |
地址 |
KR |